The forecast for bladder malignant neoplasms mortality in Brazil shows a gradual increase from 2024 to 2028, with a standardized rate rising from 4.4 to 4.6 deaths per hundred thousand persons. In 2023, the rate was 4.3, highlighting a consistent upward trend and year-on-year growth of about 1.4% in 2024 and then stabilizing to approximately 0.7% annually from 2025 to 2027. The compound annual growth rate (CAGR) over these five years is about 1.2%.
Future trends to watch for include advancements in medical treatments, early detection rates, and public health initiatives in Brazil, which could potentially mitigate the increasing mortality trend. Additionally, demographic changes and healthcare access disparities may influence future mortality rates, necessitating continuous monitoring and policy adjustments.
